FEMS Member Societies and Affiliated Organisations are organized according to the FEMS statutes. These societies and organisations may exert their rights, fulfil their duties, and claim their benefits as follows.
Member Societies are societies with a main or partial interest in microbiology, their delegates vote.
- Full Member: Full fee, eligible for benefits
- Provisional Member: Partial fee, they remain members for a limited acquainting period decided by Council then they must decide whether to take up full membership or not, eligible for benefits.
- Associate Member: Partial fee, partially for benefits
Affiliated Organisations are organisations such as enterprises, agencies, institutions. Their representatives can attend and speak at Council but cannot vote.
- Corresponding Member: Fee, partially eligible for benefits upon payment.
On this general basis the duties and rights are further specified below:
|Annual fees for Member Societies (Basis is
€1.40 per member of Member Society)
|Annual fee for Affiliated Organisations (basis is specific agreement with Corresponding Member)|
|Taking part in all activities||+||–|
|Research and Training Grants1||+||–|
|Meeting Organizer Grants1||+||–|
|Meeting Attendance Grants1||+||+|
|Journal Membership Subscription Price||+||+|
|Voting right at Council2||+||–|
|Attend and speak at Council||+||+|
|Taking part in Working Groups||+||–|
|Taking part in lobbying activities||+||–|
|Entry to website pages with restricted access||+||+|
|Promotion via website/Circular||+||–|
Note 1: benefit is lost when membership fees are more than two years in arrears (minute CO5-32/5.3)
Note 2: voting rights may be removed when membership fees are more than two years in arrears (article 23)
The investigation of novel approaches for tackling the antimicrobial resistance crisis must be part of any global response to this problem if an untimely reversion to the pre-penicillin era of medicine is to be avoided. One such promising avenue of research involves so-called antibiotic resistance breakers (ARBs), capable of re-sensitising resistant bacteria to antibiotics. This review introduces the area of ARB research, summarises the current state of ARB development with emphasis on the various major classes of ARBs currently being investigated and their modes of action, and offers a perspective on the future direction of the field.